Cargando…

Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy

BACKGROUND: Breast cancer (BC) is the most commonly diagnosed cancer in women worldwide. The challenge in managing this heterogeneous malignancy is that BC is highly aggressive and is always associated with chemical resistance, radiation resistance, hormone therapy resistance, and targeted therapy r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao, Wu, Liangliang, Zheng, Zhiying, Liu, Hanyuan, Li, Haiyang, Sun, Guoqiang, Sun, Guangshun, Cheng, Ye, Wang, Hanjin, Li, Zhouxiao, Shi, Junfeng, Tang, Weiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831063/ https://www.ncbi.nlm.nih.gov/pubmed/35154317 http://dx.doi.org/10.1155/2022/5320421

Ejemplares similares

Estimation of Tegaserod Maleate by Differential Pulse Polarography
por: Rajput, S. J., et al.
Publicado: (2009)

Upregulation of ADAR Promotes Breast Cancer Progression and Serves as a Potential Therapeutic Target
por: Li, Xiao, et al.
Publicado: (2021)

Tegaserod Maleate Inhibits Esophageal Squamous Cell Carcinoma Proliferation by Suppressing the Peroxisome Pathway
por: Wu, Xiangyu, et al.
Publicado: (2021)

Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2
por: Wang, Zitong, et al.
Publicado: (2022)

Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway
por: Guangshun, Sun, et al.
Publicado: (2022)

Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy
por: Sun, Guangshun, et al.
Publicado: (2022)

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
por: Sun, Guoqiang, et al.
Publicado: (2021)

Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
por: Hao, Xiaopei, et al.
Publicado: (2022)

Inhibition of PARP Potentiates Immune Checkpoint Therapy through miR-513/PD-L1 Pathway in Hepatocellular Carcinoma
por: Sun, Guoqiang, et al.
Publicado: (2022)

Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer
por: Zheng, Wubin, et al.
Publicado: (2021)

WNT5a in Colorectal Cancer: Research Progress and Challenges
por: Sun, Guangshun, et al.
Publicado: (2021)

Tegaserod for the Treatment of Irritable Bowel Syndrome
por: Madia, Valentina Noemi, et al.
Publicado: (2020)

Novel insights into circular RNAs in clinical application of carcinomas
por: Rong, Dawei, et al.
Publicado: (2017)

Comments on Tegaserod Trial on Irritable Bowel Syndrome
por: Jung, Hye-Kyung
Publicado: (2010)

Health literacy and functional exercise adherence in postoperative breast cancer patients
por: Tang, Weiwei, et al.
Publicado: (2017)

Treatment of patients with cancer using PD-1/PD-L1 antibodies: Adverse effects and management strategies (Review)
por: Sun, Guangshun, et al.
Publicado: (2022)

Application of Animal Models in Cancer Research: Recent Progress and Future Prospects
por: Li, Zhitao, et al.
Publicado: (2021)

Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
por: Cao, Hengsong, et al.
Publicado: (2022)

Exploratory Study of Tegaserod for Dyspepsia in Women Receiving PPIs for Heartburn
por: Vakil, Nimish, et al.
Publicado: (2008)

Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment
por: Séguy, Line, et al.
Publicado: (2021)

Inhibition of APOE potentiates immune checkpoint therapy for cancer
por: Hui, Bingqing, et al.
Publicado: (2022)

Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma
por: Kong, Xiangyi, et al.
Publicado: (2022)

Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges
por: Sun, Guangshun, et al.
Publicado: (2021)

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom
por: Layer, Peter, et al.
Publicado: (2007)

GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway
por: Rong, Dawei, et al.
Publicado: (2023)

Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges
por: Li, Zhitao, et al.
Publicado: (2021)

Tegaserod mimics the neurostimulatory glycan polysialic acid and promotes nervous system repair
por: Bushman, J., et al.
Publicado: (2013)

Trimipraminium maleate
por: Jasinski, Jerry P., et al.
Publicado: (2010)

Comprehensive Analysis of VCAN Expression Profiles and Prognostic Values in HCC
por: Sun, Guangshun, et al.
Publicado: (2022)

The Effect of Tegaserod on Symptoms and Quality of Life in Korean Women with Irritable Bowel Syndrome with Constipation
por: Kim, Yong Sung, et al.
Publicado: (2010)

Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications
por: Liu, Wei, et al.
Publicado: (2020)

The emerging landscape of circular RNAs in immunity: breakthroughs and challenges
por: Li, Zhouxiao, et al.
Publicado: (2020)

Creatininium hydrogen maleate
por: Jahubar Ali, A., et al.
Publicado: (2011)

Flunarizinium hydrogen maleate
por: Kavitha, Channappa N., et al.
Publicado: (2013)

Maleate salts of bedaquiline
por: Zeller, Matthias, et al.
Publicado: (2021)

Effects of tegaserod on bile composition and hepatic secretion in Richardson ground squirrels on an enriched cholesterol diet
por: Mathison, Ronald, et al.
Publicado: (2006)

Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers
por: Rong, Dawei, et al.
Publicado: (2021)

Hot-Melt Extrusion of the Thermo-Sensitive Peptidomimetic Drug Enalapril Maleate
por: Hoffmann, Lena, et al.
Publicado: (2022)

Up-regulation of SPC25 promotes breast cancer
por: Wang, Qian, et al.
Publicado: (2019)

Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study
por: Law, Michael R, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ah5p927p464vbgui74ciueb0vk